China moves to streamline medtech regulatory process

05/20/2013 | (Boston)

The China Food and Drug Administration has adopted measures to enhance its process for medical device classification, including setting up a system to allow firms to submit their product classification requests online. The agency also hopes to streamline the regulatory pathway for innovative devices in China by developing a special approval program for such products.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ